SCHEMBL3620136

SCHEMBL3620136

CC=C(CC(C)C)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 8/20 0.58
GRIK2 Q13002 5/20 0.58
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
GRIA2 P42262 2/20 0.42
GRIA4 P48058 2/20 0.42
GRIK3 Q13003 2/20 0.42
GRIK5 Q16478 2/20 0.42
GRIA1 P42261 1/20 0.42
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
KISS1R Q969F8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10450348 1.00 GRIK1 (0.58) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL8377796 1.00 GRIK1 (0.58) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL1972692 0.84 GRIK1 (0.44) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL2139645 0.82 GRIK1 (0.56) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL669945 0.82 GRIK1 (0.42) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL2139638 0.82 GRIK1 (0.56) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL9419755 0.80 GRIK1 (0.41) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL5544224 0.80 GRIK1 (0.64) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL7700265 0.80 KDM4E (0.50) GRIK1GRIK2ALDH1A1TDP1GRIA2
SCHEMBL9419756 0.80 GRIK1 (0.41) GRIK1GRIK2ALDH1A1TDP1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105263855-B The system and method analyzed using polymer point 华盛顿大学商业中心 2018-09-18 CN claimed
EP-2526582-B1 BINDER FOR SECONDARY BATTERY PROVIDING EXCELLENT ADHESION STRENGTH AND CYCLE PROPERTY LG CHEMICAL LTD (KR) 2015-04-22 EP claimed
US-5876492-A Ink compositions containing esters XEROX CORPORATION (US) 1999-03-02 US claimed
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 US disclosed
EP-3452536-B1 SELF-COOLING FOAM-CONTAINING COMPOSITE MATERIALS BASF SE (DE) 2024-01-17 EP disclosed
US-20220142157-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH SA (CH) 2022-05-12 US disclosed
US-20220142158-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2022-05-12 US disclosed
CN-113905612-A Arthropod control composition 弗门尼舍有限公司 2022-01-07 CN disclosed
EP-3930460-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2022-01-05 EP disclosed
EP-3930461-A1 ARTHROPOD CONTROLLING COMPOSITION Firmenich SA (CH) 2022-01-05 EP disclosed
CN-113873884-A Arthropod control composition 弗门尼舍有限公司 2021-12-31 CN disclosed
US-5047256-A Flavoring with alkyl (3-methylthio)-butyrates NAARDEN INTERNATIONAL N.V. (NL) 1991-09-10 US disclosed
EP-0185380-B1 THIOL BASED COLLAGENASE INHIBITORS G.D. Searle & Co. (US) 1990-04-11 EP disclosed
EP-0330254-A1 Alkyl (3-methylthio)-butyrates, as well as flavour compositions and flavoured foodstuffs and stimulants containing one or more of these compounds as flavour component NAARDEN INTERNATIONAL N.V. (NL) 1989-08-30 EP disclosed
US-4681966-A ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1987-07-21 US disclosed
EP-0185380-A2 Thiol based collagenase inhibitors G.D. Searle & Co. (US) 1986-06-25 EP disclosed
US-4595700-A Thiol based collagenase inhibitors G. D. SEARLE & CO. (US) 1986-06-17 US disclosed
US-4420586-A IN ORGANIC SOLVENT WITH TWO LABILE HYDROGEN ATOMS, HYDROXY GROUP, AND TERTIARY CARBON ATOM NALCO CHEMICAL COMPANY (US) 1983-12-13 US disclosed
US-4143020-A COPOLYMERS OF SULFONIC ACID MONOMERS ROHM AND HAAS COMPANY (US) 1979-03-06 US disclosed
US-4131736-A Polymers of sulfonic acid monomers ROHM AND HAAS COMPANY (US) 1978-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 GRIK1 2102/4885GRIK2 2396/4885ALDH1A1 3224/4885
US-20220142157-A1 ARTHROPOD CONTROLLING COMPOSITION AGO2, NOP2, FBL GRIK1 4194/4885GRIK2 4135/4885ALDH1A1 3272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.